Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2025)

Rapid Micro Biosystems' FCF Margin history spans 6 years, with the latest figure at 29.59% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 9441.0% to 29.59% in Q4 2025 year-over-year; TTM through Dec 2025 was 95.01%, a 6349.0% increase, with the full-year FY2025 number at 95.01%, up 6349.0% from a year prior.
  • FCF Margin hit 29.59% in Q4 2025 for Rapid Micro Biosystems, up from 124.19% in the prior quarter.
  • Over the last five years, FCF Margin for RPID hit a ceiling of 29.59% in Q4 2025 and a floor of 460.43% in Q1 2022.
  • Historically, FCF Margin has averaged 224.39% across 5 years, with a median of 192.28% in 2021.
  • Biggest five-year swings in FCF Margin: tumbled -24324bps in 2022 and later skyrocketed 26384bps in 2023.
  • Tracing RPID's FCF Margin over 5 years: stood at 285.2% in 2021, then crashed by -47bps to 420.3% in 2022, then soared by 63bps to 156.46% in 2023, then grew by 21bps to 124.0% in 2024, then surged by 76bps to 29.59% in 2025.
  • Business Quant data shows FCF Margin for RPID at 29.59% in Q4 2025, 124.19% in Q3 2025, and 130.21% in Q2 2025.